Cargando…
Sivelestat improves clinical outcomes and decreases ventilator-associated lung injury in children with acute respiratory distress syndrome: a retrospective cohort study
BACKGROUND: Sivelestat, a neutrophil elastase inhibitor, is a selective and targeted therapy for acute respiratory distress syndrome (ARDS) in adults; and it is also reported to apply to children with ARDS. However, there is little evidence of its efficacy in children. METHODS: This study recruited...
Autores principales: | Wang, Yi, Wang, Min, Zhang, Hua, Wang, Ying, Du, Yanqiang, Guo, Zhangyan, Ma, Le, Zhou, Yong, Zhang, Huiping, Liu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636449/ https://www.ncbi.nlm.nih.gov/pubmed/36345446 http://dx.doi.org/10.21037/tp-22-441 |
Ejemplares similares
-
Evaluation of appropriate indications for the use of sivelestat sodium in acute respiratory distress syndrome: a retrospective cohort study
por: Maki, Chika, et al.
Publicado: (2019) -
Effect of Sivelestat in the Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis
por: Ding, Qiongli, et al.
Publicado: (2023) -
Clinical evaluation of sivelestat for acute lung injury/acute respiratory distress syndrome following surgery for abdominal sepsis
por: Tsuboko, Yoshiaki, et al.
Publicado: (2012) -
The evaluation of sivelestat sodium hydrate in acute lung injury/acute respiratory distress syndrome patients in the intensive care unit
por: Ikeda, T, et al.
Publicado: (2007) -
Effect of sivelestat sodium in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of randomized controlled trials
por: Pu, Shenglan, et al.
Publicado: (2017)